Clinical trial
Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum…
NCT00452478 · Shire, Industry · Terminated
Key facts
| NCT number | NCT00452478 |
|---|---|
| Title | Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5 |
| Official title | A Phase IV, Open-Label, Multi-Centre Trial Evaluating the Conversion From Standard Phosphate Binder Therapy to Fosrenol® in Chronic Kidney Disease Stage 5 Patients on Haemodialysis |
| Lead sponsor | Shire, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Diseases |
| Intervention type | Drug |
| Interventions | Lanthanum carbonate |
| Enrollment | 68 |
| Start date | May 22, 2007 |
| Primary completion | Dec 10, 2007 |
| Completion | Dec 10, 2007 |
| First posted | Mar 27, 2007 |
| Last update posted | May 25, 2021 |
| Countries | Austria, Belgium, Denmark, Germany, Italy, Netherlands |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: